AMPH vs CNC · P/E 12, rev $732.0M vs P/E 8.4, rev $163.07B
Amphastar P (AMPH) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the AMPH and CNC stock pages for the full models.
Not investment advice.